GGrantIndex
← Leaderboards

Terry L. Sheppard

Keystone Symposia

$1,004,130
Attributed
$1,004,130
Total exposure
78
Grants
78
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $446.5K · FY202025
$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$1,004,130 · 78

By mechanism

R13$1,004,130 · 78

Top collaborators

No co-investigators on record.

Others in their field

Other Emerging Leaders on “Research Personnel

Research focus

Research PersonnelSymposiumCollaborationsPostersEducational WorkshopLearningScientistMethodologyClinical PracticeAreaProgramsMultidisciplinaryDesignInsightMeetingsCareerTechnologyBiologyCommunitiesFutureInterestCellsFosteringIndustry

Grant awards (78)

Spotlight on the Cancer Cell: Intrinsic Properties and Vulnerabilities for Therapeutics$19,800
R13 · FY2025 · CA · contact PI
Obesity and Adipose Tissue$19,200
R13 · FY2025 · DK · contact PI
Human Microbiome: Diversity, Selection and Adaptation$18,100
R13 · FY2025 · DK · contact PI
MASH Pathogenesis and Therapeutic Approaches$16,900
R13 · FY2025 · DK · contact PI
Drug Delivery to the Brain: Emerging Modalities$15,400
R13 · FY2025 · NS · contact PI
Somatic Mosaicism in Human Development, Aging, and Diseases$13,300
R13 · FY2025 · HG · contact PI
Trajectories to Heart Failure: Immunometabolic Mechanisms$13,000
R13 · FY2025 · HL · contact PI
Organoids: Engineering Innovative Approaches for Basic and Translational Insight$10,000
R13 · FY2025 · HD · contact PI
Malaria: Mechanisms of Immunity & Protection$7,500
R13 · FY2025 · AI · contact PI
Tuberculosis: Heterogeneity from Experimental Models to Human Disease$6,500
R13 · FY2025 · AI · contact PI
Antibodies as Drugs: Innovative Formats, Design and Engineering$4,200
R13 · FY2025 · AI · contact PI
Host-Microbe Co-Evolution in Human Health: The Microbiome-Pathobiont Continuum$4,000
R13 · FY2025 · AI · contact PI
Myeloid Cells: Roles in Different Tissue Microenvironments$3,400
R13 · FY2025 · AI · contact PI
Immunometabolism in Tissue Homeostasis and Diseases$3,200
R13 · FY2025 · AI · contact PI
Precision Genome Engineering$18,900
R13 · FY2024 · TR · contact PI
Neuroimmune Interactions: Nervous System and Immune Cell Heterogeneity in Health and Disease$18,900
R13 · FY2024 · NS · contact PI
Neurodegenerative Diseases$18,900
R13 · FY2024 · NS · contact PI
HIV and (Re)Emerging Viruses: Aligning Lessons Across Pandemics$17,700
R13 · FY2024 · AI · contact PI
Stem Cells and Regeneration$17,700
R13 · FY2024 · HL · contact PI
Hematopoiesis$17,700
R13 · FY2024 · HL · contact PI
Cardiometabolic Diseases: The Role of Ethnic Diversity in Precision Medicine$16,500
R13 · FY2024 · DK · contact PI
Delivery of Nucleic Acid Therapeutics$16,500
R13 · FY2024 · TR · contact PI
Non-coding RNA Biology: New Roles & Diversity$15,700
R13 · FY2024 · HG · contact PI
Proximity Based Therapeutics$15,300
R13 · FY2024 · TR · contact PI
Microbiota and Cancer Immunity$15,000
R13 · FY2024 · CA · contact PI
Mammalian Somatosensation: Mechanisms of Itch, Touch, Pain and Interoreception in Health and Disease$15,000
R13 · FY2024 · NS · contact PI
T Cell Differentiation in Tissue Microenvironments$15,000
R13 · FY2024 · AI · contact PI
NASH and Fibrosis: From Molecular Phenotypes to Precision Therapeutics$14,250
R13 · FY2024 · DK · contact PI
Obesity: Causes and Consequences$14,250
R13 · FY2024 · DK · contact PI
Innate Immunity Across the Molecular, Cellular, Tissue and Therapeutic$13,000
R13 · FY2024 · AI · contact PI
Epigenetic Mechanisms and the Treatment of Cancer$12,000
R13 · FY2024 · CA · contact PI
Antibodies as Drugs: The Art in Antibody Engineering$11,000
R13 · FY2024 · AI · contact PI
Regulation of Barrier Immunity$11,000
R13 · FY2024 · AI · contact PI
Tumor Metabolism$10,000
R13 · FY2024 · CA · contact PI
Innate Immune Memory: Mechanisms and Consequences$9,500
R13 · FY2024 · AI · contact PI
Fibrosis: Inflammation, Drivers, and Therapeutic Resolution$9,500
R13 · FY2024 · AI · contact PI
Cardiovascular Epigenetics and Gene Regulation$8,000
R13 · FY2024 · HL · contact PI
Tuberculosis: The Host-Pathogen Interface$7,000
R13 · FY2024 · AI · contact PI
Fungal Pathogens: Emerging Threats and Future Challenges$6,000
R13 · FY2024 · AI · contact PI
RNA Mediated Regulation of Immunity: Mechanism, Disease and Therapeutics$6,000
R13 · FY2024 · AI · contact PI
Cancer Immunotherapy: Beyond Immune Checkpoint Blockade and Overcoming Resistance$5,000
R13 · FY2024 · CA · contact PI
Positive Strand RNA Viruses: Interdisciplinary Advances in Virology, Pathogenesis, Immunology, and Technology Development$4,000
R13 · FY2024 · AI · contact PI
Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment$21,300
R13 · FY2023 · HL · contact PI
HIV Vaccines, Immunoprophylaxis and Drugs$21,300
R13 · FY2023 · AI · contact PI
Precision Genome Engineering$21,000
R13 · FY2023 · TR · contact PI
Targeted Protein Degradation$20,100
R13 · FY2023 · TR · contact PI
Organoids as Models of Development and Disease, and their Impact on Drug Discovery$19,800
R13 · FY2023 · TR · contact PI
Immunity and Aging$19,230
R13 · FY2023 · AG · contact PI
Metabolic and Molecular Mechanisms of NAFLD/NASH$19,200
R13 · FY2023 · DK · contact PI
Circulating Metabolic Intermediates as Fuels and Signals$18,900
R13 · FY2023 · DK · contact PI
Signals and Mechanisms Underlying the Benefits of Exercise$18,900
R13 · FY2023 · AR · contact PI
Molecular Basis of Healthy Aging$18,600
R13 · FY2023 · AG · contact PI
From First Breath: Lung Development, Infection, Repair and Aging$16,500
R13 · FY2023 · HL · contact PI
Heart Development and Disease: From Genes to Cures$16,200
R13 · FY2023 · HL · contact PI
Pulmonary Hypertension: State of the Art and Therapeutic Opportunities$15,300
R13 · FY2023 · HL · contact PI
Transposable Elements at the Crossroads of Evolution, Health and Disease$15,000
R13 · FY2023 · CA · contact PI
Inflammation in the Lung: Friend or Foe in Viral Infections?$15,000
R13 · FY2023 · AI · contact PI
Genomic Instability and DNA Repair$15,000
R13 · FY2023 · CA · contact PI
Metastasis$15,000
R13 · FY2023 · CA · contact PI
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers$15,000
R13 · FY2023 · AI · contact PI
Myeloid Cells: Development, Diversity and Distinct Biological Roles$14,000
R13 · FY2023 · AI · contact PI
Type 2 Diabetes: Understanding its Early Drivers and the Road to Therapeutics$13,200
R13 · FY2023 · DK · contact PI
Myeloid Cell Diversity: From Fundamental Biology to Disease States$12,500
R13 · FY2023 · AI · contact PI
Emerging Cellular Therapies at the Forefront of Cancer Immunotherapy$11,000
R13 · FY2023 · CA · contact PI
Heart Failure: All Cells Considered$10,000
R13 · FY2023 · HL · contact PI
Infections in Pregnancy: PathogenicMechanisms, Experimental Advances and Clinical Strategies$10,000
R13 · FY2023 · AI · contact PI
Inhibitory Receptors in Immune Homeostasis, Disease and Therapy$9,000
R13 · FY2023 · AI · contact PI
Innate Immunity: From Innate Sensing to Adaptive Responses$8,000
R13 · FY2023 · AI · contact PI
Vaccinology During and After COVID-19$7,500
R13 · FY2023 · AI · contact PI
RNA Modifications in Health and Disease$7,500
R13 · FY2023 · AI · contact PI
Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade$6,000
R13 · FY2023 · AI · contact PI
B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics$6,000
R13 · FY2023 · CA · contact PI
T and B Cell Collaboration in Germinal Centers and Beyond$5,500
R13 · FY2023 · AI · contact PI
Fibrosis Pathogenesis and Resolution: From Mechanisms to Therapies$5,000
R13 · FY2023 · HL · contact PI
Next Generation Antibody Therapeutics: From Discovery to Patient$14,400
R13 · FY2022 · AI · contact PI
Protein-RNA Interactions$3,500
R13 · FY2022 · CA · contact PI
Skin-Immune Crosstalk$15,900
R13 · FY2020 · AR · contact PI
Vector Biology: Emerging Concepts and Novel Technologies$10,000
R13 · FY2020 · AI · contact PI